Intraperitoneal (ip) Cisplatin-Mitoxantrone-Interferon-α2b in Ovarian Cancer Patients with Minimal Residual Disease

1993 ◽  
Vol 50 (1) ◽  
pp. 60-67 ◽  
Author(s):  
G. Frasci ◽  
A. Tortoriello ◽  
G. Facchini ◽  
S. Conforti ◽  
A. Cardone ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Interferon Α2b ◽  
Minimal Residual

The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy

1990 ◽  
Vol 39 (2) ◽  
pp. 150-154 ◽  
Author(s):  
Giorgio Bolis ◽  
Flavia Zanaboni ◽  
Paolo Vanoli ◽  
Antonio Russo ◽  
Massimo Franchi ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Advanced Ovarian Cancer ◽  
The Impact ◽  
Minimal Residual

1272 Ovarian cancer patients with minimal residual disease: TPA, CA-125 and TATI sensitivity

1995 ◽  
Vol 31 ◽  
pp. S265
Author(s):  
Z. Stanojević ◽  
M. Milutinović ◽  
N. Potic Zećevic ◽  
S. Radić ◽  
S. Filipović
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Ca 125 ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document